Figures & data
Figure 1. CTRP3 expressions in clinical vitreous samples. The mRNA expression levels of CTRP3 in vitreous samples collected from patients with DR or cataract were measured using qRT-PCR. *p < .05 vs. control.
![Figure 1. CTRP3 expressions in clinical vitreous samples. The mRNA expression levels of CTRP3 in vitreous samples collected from patients with DR or cataract were measured using qRT-PCR. *p < .05 vs. control.](/cms/asset/ef19bd55-701f-4bbb-811e-a77a625a4224/ianb_a_1666864_f0001_b.jpg)
Figure 2. CTRP3 expression in ARPE-19 cells under HG condition. ARPE-19 cells were cultured in normal glucose condition (5.5 mmol/l d-glucose) or HG condition (25 mmol/l d-glucose) for 24 h. The mRNA and protein levels of CTRP3 were determined using qRT-PCR (A) and western blot (B), respectively. *p < .05 vs. control.
![Figure 2. CTRP3 expression in ARPE-19 cells under HG condition. ARPE-19 cells were cultured in normal glucose condition (5.5 mmol/l d-glucose) or HG condition (25 mmol/l d-glucose) for 24 h. The mRNA and protein levels of CTRP3 were determined using qRT-PCR (A) and western blot (B), respectively. *p < .05 vs. control.](/cms/asset/daac987d-9484-479f-ad52-89520e78c38b/ianb_a_1666864_f0002_b.jpg)
Figure 3. Effect of CTRP3 overexpression on cell viability in HG-induced ARPE-19 cells. ARPE-19 cells were transfected with pcDNA3.1-CTRP3 or control plasmid pcDNA3.1 for 24 h and then subjected to HG condition (25 mmol/l d-glucose) for 24 h. (A,B) The expression levels of CTRP3 were determined using qRT-PCR and western blot. *p < .05 vs. cells transfected with pcDNA3.1. (C) MTT assay was performed to evaluate cell viability. *p < .05 vs. control, #p < .05 vs. HG + pcDNA3.1 group.
![Figure 3. Effect of CTRP3 overexpression on cell viability in HG-induced ARPE-19 cells. ARPE-19 cells were transfected with pcDNA3.1-CTRP3 or control plasmid pcDNA3.1 for 24 h and then subjected to HG condition (25 mmol/l d-glucose) for 24 h. (A,B) The expression levels of CTRP3 were determined using qRT-PCR and western blot. *p < .05 vs. cells transfected with pcDNA3.1. (C) MTT assay was performed to evaluate cell viability. *p < .05 vs. control, #p < .05 vs. HG + pcDNA3.1 group.](/cms/asset/c6e7c374-2ad1-4c1d-aec4-ed4dd5278fd3/ianb_a_1666864_f0003_b.jpg)
Figure 4. Effect CTRP3 overexpression on HG-induced oxidative stress in ARPE-19 cells. ARPE-19 cells were transfected with pcDNA3.1-CTRP3 or control plasmid pcDNA3.1 for 24 h and then subjected to HG condition (25 mmol/l d-glucose) for 24 h. ROS generation (A), MDA production (B) and SOD activity (C) were measured to assess oxidative stress in ARPE-19 cells. *p < .05 vs. control, #p<.05 vs. HG + pcDNA3.1 group.
![Figure 4. Effect CTRP3 overexpression on HG-induced oxidative stress in ARPE-19 cells. ARPE-19 cells were transfected with pcDNA3.1-CTRP3 or control plasmid pcDNA3.1 for 24 h and then subjected to HG condition (25 mmol/l d-glucose) for 24 h. ROS generation (A), MDA production (B) and SOD activity (C) were measured to assess oxidative stress in ARPE-19 cells. *p < .05 vs. control, #p<.05 vs. HG + pcDNA3.1 group.](/cms/asset/c23b3bff-618f-456a-b8bb-81bea76340a8/ianb_a_1666864_f0004_b.jpg)
Figure 5. Effect of CTRP3 overexpression on HG-induced cell apoptosis in ARPE-19 cells. ARPE-19 cells were transfected with pcDNA3.1-CTRP3 or control plasmid pcDNA3.1 for 24 h and then subjected to HG condition (25 mmol/l d-glucose) for 24 h. (A) Flow cytometry was applied to examine apoptotic rate of ARPE-19 cells. (B) Western blot was used for the semi-quantitative assessment of the expressions of bax and bcl-2. *p < .05 vs. control, #p < .05 vs. HG + pcDNA3.1 group.
![Figure 5. Effect of CTRP3 overexpression on HG-induced cell apoptosis in ARPE-19 cells. ARPE-19 cells were transfected with pcDNA3.1-CTRP3 or control plasmid pcDNA3.1 for 24 h and then subjected to HG condition (25 mmol/l d-glucose) for 24 h. (A) Flow cytometry was applied to examine apoptotic rate of ARPE-19 cells. (B) Western blot was used for the semi-quantitative assessment of the expressions of bax and bcl-2. *p < .05 vs. control, #p < .05 vs. HG + pcDNA3.1 group.](/cms/asset/40e895ff-d575-4b02-b621-2f9fb0728730/ianb_a_1666864_f0005_c.jpg)
Figure 6. Effect of CTRP3 overexpression on Nrf2/HO-1 pathway in HG-stimulated ARPE-19 cells. (A) Western blot was used for the semi-quantitative assessment of the expressions of nuclear Nrf2 and HO-1. (B, C) The relative intensities of nuclear Nrf2 and HO-1 were determined. *p < .05 vs. HG + pcDNA3.1 group.
![Figure 6. Effect of CTRP3 overexpression on Nrf2/HO-1 pathway in HG-stimulated ARPE-19 cells. (A) Western blot was used for the semi-quantitative assessment of the expressions of nuclear Nrf2 and HO-1. (B, C) The relative intensities of nuclear Nrf2 and HO-1 were determined. *p < .05 vs. HG + pcDNA3.1 group.](/cms/asset/2fbf186d-1917-44ef-98d4-fed72ef82edb/ianb_a_1666864_f0006_b.jpg)
Figure 7. Nrf2 knockdown reversed CTRP3-mediated oxidative stress and apoptosis. ARPE-19 cells were co-transfected with pcDNA3.1-CTRP3 and siRNA-Nrf2 for 24 h and then subjected to HG condition (25 mmol/l d-glucose) for 24 h. (A) MTT assay was performed to evaluate cell viability. (B) ROS production was measured using DCFH-DA. (C) Cell apoptosis was quantified by flow cytometry using an Annexin V-FITC/PI double staining assay kit. *p < .05.
![Figure 7. Nrf2 knockdown reversed CTRP3-mediated oxidative stress and apoptosis. ARPE-19 cells were co-transfected with pcDNA3.1-CTRP3 and siRNA-Nrf2 for 24 h and then subjected to HG condition (25 mmol/l d-glucose) for 24 h. (A) MTT assay was performed to evaluate cell viability. (B) ROS production was measured using DCFH-DA. (C) Cell apoptosis was quantified by flow cytometry using an Annexin V-FITC/PI double staining assay kit. *p < .05.](/cms/asset/c8d19fa0-bb73-4e86-b3ea-86fe854483a1/ianb_a_1666864_f0007_b.jpg)